Skip to content

Comparison Of Pre Emptive Medication In Attenuation Of Pressor Changes To Laryngoscopy And Intubation In Abdominal Laproscopic Surgeries

Comparison of pre emptive medication of pregabalin, clonidine and melatonin in attenuation of pressor responses to laryngoscopy and intubation in abdominal laproscopic surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033968
Enrollment
90
Registered
2021-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: pregabalin 150 mg oral tablet clonidine200mcg oral tablet melatonin6 mg oral tablet : given 2hours before start of surgery with a sip of water and hemodynamic parameters studied mainly

Sponsors

Otherself
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II between the age group 20 years and 60 years of either sex with written informed consent will be randomly selected who are undergoing laproscopic abdominal surgeries under general anaesthesia.

Exclusion criteria

Exclusion criteria: Patient with preexisting cardiac disease Hypertension Asthma Severe renal or hepatic dysfunction Patients with anticipated difficult intubation Pregnancy Patient with known allergy to study drugs

Design outcomes

Primary

MeasureTime frame
To access the efficacy of oral pregabalin, oral melatonin and oral clonidine on hemodynamic changes during laryngoscopy and intubationTimepoint: at 1 min, 3 min, 5 min., followed by every 10 min.

Secondary

MeasureTime frame
To assess the effectiveness of test drugs in reducing pre operative anxiety and post operative pain.Timepoint: at 1 min, 3 min, 5 min., followed by every 10 min.

Countries

India

Contacts

Public ContactVishakha Tanwar

Mahatma Gandhi University of Medical Science and Technology

drpriyamvada@hotmail.co.uk09413418336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026